Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 333.00
-6.00 (-1.77%)
May 12, 2026, 3:30 PM JST
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 44.96 billion as of May 12, 2026. Its market cap has increased by 72.41% in one year.
Market Cap
44.96B
Enterprise Value
41.90B
Revenue
104.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
333.00
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 44.96B, a decrease of -32.98%. That is a compound annual growth rate of -3.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 44.96B | 42.11% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takara Bio | 137.51B |
| Nxera Pharma | 107.05B |
| Oncolys BioPharma | 85.45B |
| Cuorips | 52.44B |
| Japan Tissue Engineering | 23.88B |
| AnGes | 21.01B |
| RaQualia Pharma | 20.68B |
| StemRIM | 18.80B |